Philip Welsh

527 total citations
15 papers, 456 citations indexed

About

Philip Welsh is a scholar working on Neurology, Biotechnology and Molecular Biology. According to data from OpenAlex, Philip Welsh has authored 15 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 6 papers in Biotechnology and 5 papers in Molecular Biology. Recurrent topics in Philip Welsh's work include Neuroblastoma Research and Treatments (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Transgenic Plants and Applications (5 papers). Philip Welsh is often cited by papers focused on Neuroblastoma Research and Treatments (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Transgenic Plants and Applications (5 papers). Philip Welsh collaborates with scholars based in United States and United Kingdom. Philip Welsh's co-authors include Arthur E. Frankel, Michael R. Zalutsky, Jon D. Robertus, J P Richardson, David M. Schlossman, D A Withers, Gamal Akabani, Ganesan Vaidyanathan, Roy H. Larsen and Kevin L. Alston and has published in prestigious journals such as Molecular and Cellular Biology, Bioconjugate Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Philip Welsh

15 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Welsh United States 12 233 213 146 139 52 15 456
LM Chelstrom United States 11 184 0.8× 90 0.4× 28 0.2× 136 1.0× 11 0.2× 15 384
Maria‐Ana Ghetie United States 6 282 1.2× 173 0.8× 135 0.9× 158 1.1× 4 0.1× 9 392
David Passmore United States 15 293 1.3× 208 1.0× 322 2.2× 424 3.1× 3 0.1× 24 724
K A Krolick United States 13 367 1.6× 165 0.8× 275 1.9× 158 1.1× 9 0.2× 20 598
William P. Bozza United States 12 98 0.4× 41 0.2× 13 0.1× 264 1.9× 21 0.4× 15 441
Nobuto Koyama Japan 11 166 0.7× 72 0.3× 44 0.3× 334 2.4× 12 0.2× 14 516
Susan L. Bernhard United States 10 171 0.7× 87 0.4× 197 1.3× 209 1.5× 7 0.1× 13 382
Kris Barreto Canada 16 57 0.2× 44 0.2× 249 1.7× 329 2.4× 48 0.9× 32 611
Marlis Hirschi Switzerland 8 104 0.4× 25 0.1× 54 0.4× 240 1.7× 10 0.2× 12 434
Arnaud Briat France 13 30 0.1× 66 0.3× 77 0.5× 235 1.7× 27 0.5× 23 440

Countries citing papers authored by Philip Welsh

Since Specialization
Citations

This map shows the geographic impact of Philip Welsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Welsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Welsh more than expected).

Fields of papers citing papers by Philip Welsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Welsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Welsh. The network helps show where Philip Welsh may publish in the future.

Co-authorship network of co-authors of Philip Welsh

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Welsh. A scholar is included among the top collaborators of Philip Welsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Welsh. Philip Welsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Vaidyanathan, Ganesan, Donna J. Affleck, Xiao-Guang Zhao, et al.. (2012). SIB-DOTA: A trifunctional prosthetic group potentially amenable for multi-modal labeling that enhances tumor uptake of internalizing monoclonal antibodies. Bioorganic & Medicinal Chemistry. 20(24). 6929–6939. 9 indexed citations
2.
Vaidyanathan, Ganesan, Donna J. Affleck, Kevin L. Alston, Philip Welsh, & Michael R. Zalutsky. (2004). Catabolism of 4-fluoro-3-iodobenzylguanidine and meta-iodobenzylguanidine by SK-N-SH neuroblastoma cells. Nuclear Medicine Communications. 25(9). 947–955. 4 indexed citations
3.
Boyd, Marie, Robert J. Mairs, W. Nicol Keith, et al.. (2004). An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation‐mediated bystander effects. The Journal of Gene Medicine. 6(8). 937–947. 47 indexed citations
4.
Vaidyanathan, Ganesan, et al.. (2004). Meta-iodobenzylguanidine derivatives containing a second guanidine moiety. Bioorganic & Medicinal Chemistry. 12(7). 1649–1656. 11 indexed citations
5.
Foulon, Catherine, Philip Welsh, Darell D. Bigner, & Michael R. Zalutsky. (2001). Positively charged templates for labeling internalizing antibodies: comparison of N -succinimidyl 5-iodo-3-pyridinecarboxylate and the D-amino acid peptide KRYRR. Nuclear Medicine and Biology. 28(7). 769–777. 14 indexed citations
6.
Vaidyanathan, Ganesan, et al.. (2001). Biological Evaluation of Ring- and Side-Chain-Substituted m-Iodobenzylguanidine Analogues. Bioconjugate Chemistry. 12(5). 798–806. 14 indexed citations
7.
Vaidyanathan, Ganesan, et al.. (2001). Ring‐and side‐chain‐substituted MIBG analogues. Journal of Labelled Compounds and Radiopharmaceuticals. 44(S1). 1 indexed citations
8.
Vaidyanathan, Ganesan, Donna J. Affleck, Philip Welsh, et al.. (2000). Radioiodination and astatination of octreotide by conjugation labeling. Nuclear Medicine and Biology. 27(4). 329–337. 20 indexed citations
9.
Larsen, Roy H., Gamal Akabani, Philip Welsh, & Michael R. Zalutsky. (1998). The Cytotoxicity and Microdosimetry of Astatine-211-Labeled Chimeric Monoclonal Antibodies in Human Glioma and Melanoma Cells In Vitro. Radiation Research. 149(2). 155–155. 53 indexed citations
10.
Garg, Pradeep, Kevin L. Alston, Philip Welsh, & Michael R. Zalutsky. (1996). Enhanced Binding and Inertness to Dehalogenation of α-Melanotropic Peptides Labeled Using N-Succinimidyl 3-Iodobenzoate. Bioconjugate Chemistry. 7(2). 233–239. 45 indexed citations
11.
Gould, Jane H., Martin R. Hartley, Philip Welsh, et al.. (1991). Alteration of an amino acid residue outside the active site of the ricin A chain reduces its toxicity towards yeast ribosomes. Molecular and General Genetics MGG. 230(1-2). 81–90. 14 indexed citations
12.
Frankel, Arthur E., Philip Welsh, J P Richardson, & Jon D. Robertus. (1990). Role of arginine 180 and glutamic acid 177 of ricin toxin A chain in enzymatic inactivation of ribosomes.. Molecular and Cellular Biology. 10(12). 6257–6263. 84 indexed citations
13.
Schlossman, David M., D A Withers, Philip Welsh, et al.. (1989). Role of glutamic acid 177 of the ricin toxin A chain in enzymatic inactivation of ribosomes.. Molecular and Cellular Biology. 9(11). 5012–5021. 68 indexed citations
14.
Withers, David R., et al.. (1989). Role of Glutamic Acid 177 of the Ricin Toxin A Chain in Enzymatic Inactivation of Ribosomes. Molecular and Cellular Biology. 9(11). 5012–5021. 19 indexed citations
15.
Frankel, Arthur E., David M. Schlossman, Philip Welsh, et al.. (1989). Selection and characterization of ricin toxin A-chain mutations in Saccharomyces cerevisiae.. Molecular and Cellular Biology. 9(2). 415–420. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by LM Chelstrom Breakdown of academic impact, for papers by Maria‐Ana Ghetie Breakdown of academic impact, for papers by David Passmore Breakdown of academic impact, for papers by K A Krolick Breakdown of academic impact, for papers by William P. Bozza Breakdown of academic impact, for papers by Nobuto Koyama Breakdown of academic impact, for papers by Susan L. Bernhard Breakdown of academic impact, for papers by Kris Barreto Breakdown of academic impact, for papers by Marlis Hirschi Breakdown of academic impact, for papers by Arnaud Briat
Rankless by CCL
2026